Skip to main content
$13.91 $0.07 (0.5%)

04:00 PM EDT on 07/27/21

Viatris, Inc. (NASDAQ:VTRS)

CAPS Rating: 3 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Current Price $13.91 Mkt Cap $16.7B
Open $13.81 P/E Ratio 0.00
Prev. Close $13.91 Div. (Yield) $0.44 (3.2%)
Daily Range $13.70 - $13.95 Volume 5,219,311
52-Wk Range $12.94 - $18.86 Avg. Daily Vol. 6,302,836

Caps

How do you think NASDAQ:VTRS will perform against the market?

Add Stock to CAPS Watchlist

All Players

618 Outperform
46 Underperform
 

All-Star Players

103 Outperform
7 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:VTRS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

ruinas (< 20)
Submitted September 25, 2015

continued improving earnings as patents expired for big pharma

DouglasRich (< 20)
Submitted January 29, 2008

Mylan is known for making good quality, reliable generic pharmaceutical products, but I think their primary drawback is they haven't found a way to outcompete the generic market. In the pharmacy, cheaper generics are preferred to Mylan's oftentimes… More

NASDAQ:VTRS VS S&P 500 (SPY)

Fools bullish on NASDAQ:VTRS are also bullish on:

Fools bearish on NASDAQ:VTRS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about VTRS.

Recs

0
Member Avatar Dividends500 (81.92) Submitted: 7/8/2021 1:15:04 PM : Outperform Start Price: $13.91 NASDAQ:VTRS Score: -1.82

Dividends500 tracks the healthiest dividends in the S&P 500.

To qualify for the portfolio, the company must meet three simple requirements:

- Member of the S&P 500
- Payout ratio below 50%
- Dividend growth year over year

Recs

0
Member Avatar Car12703 (57.35) Submitted: 7/8/2021 9:43:56 AM : Outperform Start Price: $13.79 NASDAQ:VTRS Score: -1.70

From Fidelity July 2021:
Revenue Growth (Last 5 Years) = 4.9%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 69.2%
Price/Sales (TTM) = 0.9

Recs

0
Member Avatar TMFjimhalley (37.08) Submitted: 5/23/2021 11:51:28 AM : Outperform Start Price: $15.37 NASDAQ:VTRS Score: -14.72

This is the largest pharmaceutical company in the world by revenue. It is very underpriced considering its earnings and the fact it offers a decent dividend. It is bound to go up as investors warm up to the company.

Leaderboard

Find the members with the highest scoring picks in VTRS.

Score Leader

heftyjeffy

heftyjeffy (< 20) Score: +404.50

The Score Leader is the player with the highest score across all their picks in VTRS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
heftyjeffy < 20 1/26/2009 Underperform 1Y $10.70 +29.95% +434.46% +404.50 0 Comment
SpecBull 60.14 5/1/2009 5/17/2009 Underperform 3W $13.27 +4.86% +407.32% +402.47 0 Comment
alley11 < 20 5/1/2009 Underperform 3W $13.27 +4.86% +407.32% +402.47 0 Comment
GenericMike 22.97 7/10/2009 Underperform 3M $12.08 +15.11% +402.07% +386.96 0 Comment
wcwhiner 27.34 7/23/2009 Underperform 5Y $13.33 +4.38% +350.69% +346.30 0 Comment
aguacer0 50.11 7/28/2009 Underperform 3W $12.60 +10.39% +350.31% +339.92 0 Comment
Spelunkin 24.83 11/5/2009 Underperform 5Y $16.88 -17.60% +315.49% +333.09 0 Comment
TrackDuality < 20 11/6/2009 Underperform 5Y $17.16 -18.93% +313.15% +332.08 0 Comment
GoodbyeForNow 98.39 10/8/2009 Underperform 5Y $16.63 -16.37% +312.02% +328.39 0 Comment
39272x4 < 20 11/9/2009 Underperform 5Y $17.39 -20.00% +306.68% +326.67 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for VTRS.